NASDAQ:ANTX | ROE | AN2 Therapeutics, Inc.

Complete source-backed roe history.

Available history
2021-12-31 to 2026-06-30
Data captured

Historical ROE

DateROE
2026-06-30-47.73%
2026-03-31-42.22%
2025-12-31-66.22%
2025-09-30-56.29%
2025-06-30-54.30%
2025-03-31-61.85%
2024-12-31-62.70%
2024-09-30-69.27%
2024-06-30-65.77%
2024-03-31-59.73%
2023-12-31-51.94%
2023-09-30-42.94%
2023-06-30-61.88%
2023-03-31-58.93%
2022-12-31-42.94%
2022-09-30-34.72%
2022-06-30-27.85%
2022-03-31-23.52%
2021-12-3145.44%

Annual ROE

DateROE
2025-12-31-66.29%
2024-12-31-62.70%
2023-12-31-51.91%
2022-12-31-42.94%
2021-12-3145.44%